News and Announcements
Significant Advance in Development of Actinogen’s Alzheimer’s Drug
- Published December 19, 2016 1:09PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th December 2016 – ASX Announcement
- Xanamem™ human research data accepted for publication in major medical journal
- Xanamem™ specifically designed to inhibit excess cortisol production in the brain
- Excess cortisol in the brain associated with Alzheimer’s disease
- Xanamem™ being trialled in Alzheimer’s disease to confirm earlier treatment success
In significant advance in the development of Xanamem™, Actinogen Medical Ltd (ASX: ACW) in pleased to announce that their human research data on Xanamem™ has been accepted for publication in the prestigious pee-reviewed medical journal – the British Journal of Pharmacology. The paper: Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteriod dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™) will be available online early in the new year.
To view the full announcement please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
